Raymond James Financial
OM icon

Raymond James Financial’s Outset Medical OM Stock Holding History

Raymond James Financial’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11
Closed -$211 – 6180
2025
Q2 		$211 Buy
+11
New +$172 ﹤0.01% 6776

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Raymond James Financial's OM Position: Q3 2025 in Review

Raymond James Financial sold out of Outset Medical (OM) in Q3 2025, closing a stake of 11 shares — an estimated $211 sold.

Raymond James Financial first reported a position in OM in Q2 2025 and held it in 1 quarter. The position peaked at $211 in Q2 2025. 101 funds tracked by Wall St. Rank hold OM as of Q3 2025.

  • Raymond James Financial reported no remaining Outset Medical position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 11 Outset Medical shares in Q3 2025, an estimated $211.
  • Raymond James Financial first reported a position in Outset Medical in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's Outset Medical position peaked at $211 in Q2 2025.
  • 101 funds tracked by Wall St. Rank held Outset Medical as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.